Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 7 studies | 23% ± 9% | |
mast cell | 4 studies | 25% ± 8% | |
glutamatergic neuron | 4 studies | 30% ± 15% | |
interneuron | 4 studies | 30% ± 16% | |
microglial cell | 4 studies | 23% ± 2% | |
oligodendrocyte | 4 studies | 21% ± 3% | |
epithelial cell | 3 studies | 22% ± 5% | |
abnormal cell | 3 studies | 18% ± 3% | |
macrophage | 3 studies | 19% ± 4% | |
astrocyte | 3 studies | 26% ± 4% | |
oligodendrocyte precursor cell | 3 studies | 28% ± 2% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 6 studies | 26% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 4592.00 | 1445 / 1445 | 100% | 48.24 | 183 / 183 |
breast | 100% | 4428.83 | 459 / 459 | 100% | 41.72 | 1116 / 1118 |
stomach | 100% | 3307.31 | 359 / 359 | 100% | 35.16 | 285 / 286 |
intestine | 100% | 4671.60 | 966 / 966 | 100% | 32.78 | 525 / 527 |
prostate | 100% | 4905.17 | 245 / 245 | 100% | 33.96 | 500 / 502 |
lung | 100% | 4242.17 | 578 / 578 | 100% | 32.19 | 1150 / 1155 |
ovary | 100% | 5728.24 | 180 / 180 | 100% | 36.75 | 428 / 430 |
bladder | 100% | 4670.52 | 21 / 21 | 99% | 28.07 | 501 / 504 |
skin | 100% | 4191.20 | 1809 / 1809 | 99% | 30.55 | 468 / 472 |
thymus | 100% | 4740.94 | 653 / 653 | 99% | 31.60 | 599 / 605 |
pancreas | 100% | 2509.64 | 327 / 328 | 99% | 27.61 | 176 / 178 |
uterus | 100% | 5775.28 | 170 / 170 | 98% | 34.81 | 452 / 459 |
brain | 98% | 2541.79 | 2598 / 2642 | 100% | 26.36 | 702 / 705 |
kidney | 100% | 3001.06 | 89 / 89 | 95% | 22.01 | 855 / 901 |
adrenal gland | 100% | 4421.44 | 258 / 258 | 94% | 18.98 | 216 / 230 |
liver | 100% | 1667.85 | 226 / 226 | 80% | 11.60 | 325 / 406 |
adipose | 100% | 4193.83 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 4167.08 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 4919.97 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 37.05 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.48 | 1 / 1 |
muscle | 100% | 2257.07 | 802 / 803 | 0% | 0 | 0 / 0 |
heart | 100% | 2251.36 | 858 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 20.44 | 78 / 80 |
lymph node | 0% | 0 | 0 / 0 | 97% | 22.31 | 28 / 29 |
peripheral blood | 96% | 2923.60 | 888 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007221 | Biological process | positive regulation of transcription of Notch receptor target |
GO_0006468 | Biological process | protein phosphorylation |
GO_0003162 | Biological process | atrioventricular node development |
GO_0060928 | Biological process | atrioventricular node cell development |
GO_0007219 | Biological process | Notch signaling pathway |
GO_0045445 | Biological process | myoblast differentiation |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0010831 | Biological process | positive regulation of myotube differentiation |
GO_0016607 | Cellular component | nuclear speck |
GO_0005654 | Cellular component | nucleoplasm |
GO_0002193 | Cellular component | MAML1-RBP-Jkappa- ICN1 complex |
GO_0005634 | Cellular component | nucleus |
GO_0042605 | Molecular function | peptide antigen binding |
GO_0003713 | Molecular function | transcription coactivator activity |
GO_0019901 | Molecular function | protein kinase binding |
GO_0005515 | Molecular function | protein binding |
Gene name | MAML1 |
Protein name | Mastermind-like protein 1 (Mam-1) |
Synonyms | KIAA0200 |
Description | FUNCTION: Acts as a transcriptional coactivator for NOTCH proteins. Has been shown to amplify NOTCH-induced transcription of HES1. Enhances phosphorylation and proteolytic turnover of the NOTCH intracellular domain in the nucleus through interaction with CDK8. Binds to CREBBP/CBP which promotes nucleosome acetylation at NOTCH enhancers and activates transcription. Induces phosphorylation and localization of CREBBP to nuclear foci. Plays a role in hematopoietic development by regulating NOTCH-mediated lymphoid cell fate decisions. . |
Accessions | ENST00000638220.2 ENST00000292599.4 Q92585 |